Depression and Anxiety Trial, Recruiting NCT06732128 Sponsor: Centre for Addiction and Mental Health Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06732128
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with mild to early-moderate stage Alzheimer's disease (which may include a mix of Alzheimer's and another type of dementia), based on standard medical guidelines
  • You are 50 years of age or older
  • Your overall health is stable enough to take part in the trial
  • Your score on a depression questionnaire (called the Patient Health Questionnaire) falls between 5 and 14, indicating a mild to moderate level of depressive symptoms
  • The trial doctor believes you are comfortable enough with technology to participate
  • You have access to WiFi and a smartphone or tablet that can run WebEx, Fitbit, and Muse apps
  • You have someone (such as a family member or caregiver) who can be present with you during all sessions

Who may not be able to join:

  • You have an unstable medical or mental health condition, including issues with substance use, as determined by the trial doctor
  • You have vision or hearing problems that would make it difficult to take part in the trial
  • Your score on the depression questionnaire is between 15 and 27, or you have a specific high-risk response on a separate depression assessment tool used for people with dementia (confirm with trial site)
  • The trial doctor believes, for any other reason, that taking part in the study would be too difficult or unsuitable for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: HARMEHR SEKHON, PhD, CAMH and McGill/St. Mary's Research Centre

Phone: (416) 535-8501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre for Addiction and Mental Health
Registry
ClinicalTrials.gov
Start date
6 January 2025
Est. completion
11 June 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Tolerability of nature-based virtual reality; Feasibility of nature-based virtual reality; Acceptability of nature-based virtual reality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov